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Abstract 
   Transcription factor Runx1 controls the cell type specification of peptidergic and 
nonpeptidergic nociceptive dorsal root ganglion (DRG) neurons by repressing TrkA and 
calcitonin gene-related peptide (CGRP) expression and activating Ret expression during 
late embryonic and early postnatal periods (Chen et al., 2006; Kramer et al., 2006; 
Yoshikawa et al., 2007). Because Runx1 is expressed in DRG from early developmental 
stages, we examined the roles of Runx1 in the proliferation and the neuronal 
differentiation of DRG cells. We used transgenic Runx1-deficient (Runx1
–/–
::Tg) mice 
which are rescued from early embryonic lethality by selective expression of Runx1 in 
hematopoietic cells under the control of GATA-1 promoter. We found that 
TrkA-expressing (TrkA
+
) DRG neurons were decreased at embryonic day (E) 12.5 in 
contrast to the previous study showing that TrkA
+
 DRG neurons were increased at 
E17.5 in Runx1
–/–
::Tg mice (Yoshikawa et al., 2007). The number of DRG neurons which 
express neuronal markers Hu, NeuN and Islet1 was also reduced in Runx1
–/–
::Tg mice at 
E12.5, suggesting that the neuronal differentiation was suppressed in these mice. The 
cell cycle analysis using BrdU/IDU revealed that the number of DRG cells in S-phase 
and G2/M-phase was increased in Runx1
–/–
::Tg mice at E12.5, while the length of 
S-phase was not changed between Runx1
+/+
::Tg and Runx1
–/–
::Tg mice, suggesting that 
Runx1 negatively controls the proliferation of DRG progenitor cell subpopulation in 
early embryonic period. Hes1 is a negative regulator of neuronal differentiation 
(Ishibashi et al., 1995; Tomita et al., 1996), and we found that the number of Hes1
+
 DRG 
cells was increased in Runx1
–/–
::Tg mice at E12.5. In summary, the present study 
suggests a novel function that Runx1 activates the neuronal differentiation of DRG cell 
subpopulation through the repression of Hes1 expression in early embryonic period.  
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Introduction 
   Runt-related (Runx) transcription factor family has the highly conserved Runt DNA 
binding domain and comprises three members: Runx1, 2, and 3 in mammal. These Runxs 
play important roles in cell proliferation and differentiation of various cell types, including 
hematopoietic cells, osteoblasts, and gastric epithelial cells (Komori et al., 1997; Levanon et 
al., 2001; Wang et al., 1996; for reviews, see Coffman, 2003; Ito, 2004, 2008). In addition, 
the anomaly of Runxs has been shown to be involved in various human diseases (Ito et al., 
2005, 2008; Li et al., 2002; Otto et al., 1997; for reviews, see Ito, 2004, 2008). Runx1 and 
Runx3 are also expressed in neuronal subtypes in the embryonic nervous systems (Levanon 
et al., 2001; Simeone et al., 1995; for reviews, see Inoue et al., 2008; Stifani and Ma, 2009). 
In the dorsal root ganglion (DRG), Runx1 and Runx3 are expressed in a subpopulation of 
sensory neurons and control the cell fate specification and the axonal projections of 
nociceptive and proprioceptive DRG neurons, respectively (Chen et al., 2006a, b; Inoue et al., 
2002, 2007; Kramer et al., 2006; Levanon et al., 2002; Marmigère et al., 2006; Nakamura et 
al., 2008; Yoshikawa et al., 2007; for reviews, see Inoue et al., 2008; Marmigère and Ernfors, 
2007; Stifani and Ma, 2009). In particular, Runx1 is initially expressed in nerve growth factor 
(NGF) receptor TrkA-expressing (TrkA
+
) neurons from the early developing period, and is 
involved in the segregation of these neurons into TrkA
+
/calcitonin gene-related peptide 
(CGRP)
+
 peptidergic nociceptive neurons and Runx1
+
/glial cell-derived neurotrophic factor 
(GDNF) receptor Ret
+
 nonpeptidergic nociceptive neurons by inhibiting the expression of 
TrkA and CGRP and promoting the Ret expression in DRG neurons from the late embryonic 
to postnatal period (Chen et al., 2006b; Kramer et al., 2006; Marmigère et al., 2006; 
Yoshikawa et al., 2007).  
   In the nasal cavity, Runx1 is expressed in proliferating cells in the olfactory epithelium. 
Runx1 deficiency reduces proliferation and causes premature differentiation of olfactory 
receptor neuron (ORN) precursors, suggesting that Runx1 coordinates the proliferation and 
differentiation of ORN precursors (Theriault et al., 2005). In DRG, proliferation of 
presumptive neurons occurs for several days around E12.5 in the lumbar segments (Lawson 
and Biscoe, 1979), while Runx1 expression begins in the same segments as early as E12.5 
(Chen et al., 2006b), showing the overlap between the cell proliferation and the onset of 
Runx1 expression in DRG. We have previously shown that Runx1 inhibits proliferation of 
DRG cells between E11.5 and E13.5, although we did not characterize proliferating cell types 
as neuronal or non-neuronal cells (Yoshikawa et al., 2007). These results suggest that Runx1 
has another roles in the proliferation and differentiation of DRG neurons during the early 
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developmental stage, in addition to the subtype specification of nociceptive DRG neurons in 
the late developmental period.  
   In the present study, to elucidate roles of Runx1 in the early stage of DRG neuron 
differentiation, we analyzed the proliferation and the cell fates of DRG neuron in Runx1 
deficient mice. 
 
 
Results 
 
Transient decrease of DRG neurons in Runx1–/– ∷Tg mice during the early stage of the 
development 
   We have previously shown that the number of TrkA
+
 DRG neurons was increased to 
143% in E17.5 Runx1
–/–
::Tg mice as compared with Runx1
+/+
::Tg mice (Yoshikawa et al., 
2007). Then, we examined the expression of TrkA in early stage of DRG neuronal 
development (Fig. 1). At E11.5, the number of TrkA
+
 DRG neurons was not different 
between Runx1
+/+
::Tg and Runx1
–/–
::Tg mice (Fig. 1A, D, and G, Table1). In contrast, TrkA
+
 
DRG neurons in Runx1
–/–
::Tg mice was decreased to 71% as compared with Runx1
+/+
::Tg 
mice at E12.5 (Fig. 1B, E, and G, Table1). At E13.5, the number of TrkA
+
 DRG neurons was 
not changed between Runx1
+/+
::Tg and Runx1
–/–
::Tg mice (Fig. 1C, F, and G, Table1). There 
was no significant difference in the number of TrkC
+
 DRG neurons between the two 
genotypes at E12.5 (Fig. 1H-J, Table1). 
   Next, we examined whether the loss of Runx1 affects the total number of DRG neurons 
from E11.5 to E13.5, using NeuN as a pan-neuronal marker (Fig. 2, Table1). The number of 
NeuN
+
 DRG neurons was not different between Runx1
+/+
::Tg and Runx1
–/–
::Tg mice at E11.5 
(Fig. 2A, D, and G, Table1). In contrast, the number of NeuN
+
 DRG neurons in Runx1
–/–
::Tg 
mice was decreased to 84% at E12.5 as compared with Runx1
+/+
::Tg mice (Fig. 2B, E, and G, 
Table1), and 90% at E13.5 (Fig. 2C, F, and G, Table1). Because the decrease in the number 
of NeuN
+
 DRG neurons at E12.5 and E13.5 may be due to the reduction of total DRG cells, 
we examined the number of total DRG cells using DAPI and the volume of DRG at E12.5 
(Fig. 3A-D, Table1). There was no significant difference in the number of DAPI
+
 cells 
between Runx1
+/+
::Tg and Runx1
–/–
::Tg mice at E12.5 (Fig. 3A-C, Table1). Similarly, the 
DRG volume was not changed between Runx1
+/+
::Tg (44.6 ± 1.6 × 10
5
 µm
3
) and 
Runx1
–/–
::Tg mice (45.9 ± 2.1 × 10
5
 µm
3
) at E12.5 (Fig. 3D). Moreover, to clarify whether 
the effects of Runx1 deficiency on the apoptosis of DRG, we examined the number of 
caspase3
+
 DRG cells at E11.5 and E12.5 (Fig. 3E-I, Table1). The number of caspase3
+
 DRG 
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cells was not changed between Runx1
+/+
::Tg and Runx1
–/–
::Tg mice both at E11.5 and E12.5 
(Fig. 3E-H, Table1). These results suggest that Runx1 positively regulates the total number of 
DRG neurons without affecting the cell survival.  
   To clarify whether the decrease in the number of NeuN
+
 DRG neuron in Runx1
-/-
::Tg 
mice represents the defects in the neuronal differentiation, we examined the number of DRG 
neurons at E12.5 using two pan-neuronal markers, Hu RNA-binding protein and Islet1 
transcription factor (Akamatsu et al., 2005; Avivi et al., 1999; Wakamatsu et al., 1997) (Fig. 
4). Compared with Runx1
+/+
::Tg mice, the numbers of Hu
+
 and Islet1
+
 DRG neurons were 
decreased to 88% and 84% in E12.5 Runx1
–/–
::Tg mice, respectively (Fig. 4, Table1). These 
results strongly suggest that Runx1 plays roles in promoting the DRG neuronal differentiation 
in the early developmental period.  
 
Cell cycle analysis of DRG cells in Runx1
–/– ∷Tg mice 
   It was reported that the length of cell cycle affects the cell fate determination (Wilcock et 
al., 2007). Then we analyzed the length of cell cycle in Runx1
–/–∷Tg mice at E12.5 (Fig. 5). 
The length of S-phase was calculated by the number of BrdU
+
/IDU
+
 S-phase cells and 
BrdU
–
/IDU
+
 G2/M-phase cells (see Materials and Methods). The number of BrdU
+
/IDU
+
 
S-phase DRG cells was increased to 123% (p <0.05) in Runx1
–/–
::Tg (1017.3 ± 59.0) as 
compared with Runx1
+/+
::Tg mice (826.8 ± 58.9) (Fig. 5B-D). Similarly, the number of 
BrdU
–
/IDU
+
 G2/M-phase cells was increased to 159% (180.3 ± 20.1 for Runx1
+/+
::Tg vs. 
286.9 ± 41.7 for Runx1
–/–
::Tg, p <0.05) (Fig. 5B, C, and E). By contrast, there was no 
significant difference in the length of S-phase between Runx1
+/+
::Tg and Runx1
–/–
::Tg mice 
(7.5 ± 1.2 h vs. 5.9 ± 2.2 h) (Fig. 5F). These results suggest that Runx1 suppresses the DRG 
cell proliferation without effects on the length of S-phase.  
 
Increase of Hes1
+
 DRG cells in Runx1
–/–∷Tg mice 
   To gain further insight into the roles of Runx1 in the differentiation of DRG neurons, we 
focused on a basic helix-loop-helix protein Hes1, because Hes1 has been shown to inhibit 
neuronal differentiation (Cau et al., 2000; Ishibashi et al., 1995; Tomita et el., 1996). At 
E11.5, similar number of Hes1
+
 DRG cells was observed in Runx1
+/+
::Tg and Runx1
–/–
::Tg 
mice (852.3 ± 11.9 vs. 896.0 ± 35.0) (Fig. 6A, B, and E). In contrast, the number of Hes1
+
 
cells in Runx1
–/–
::Tg DRG was increased to 120% (1150.3 ± 56.1 vs. 1385.8 ± 63.1, p <0.05) 
compared with Runx1
+/+
::Tg DRG at E12.5 (Fig. 6C, D, and E). Next, we examined the 
co-localization of Runx1 and Hes1 in Runx1
+/+
::Tg DRG at E12.5. Many Runx1
+
 DRG cells 
did not express Hes1 (Fig. 6F-H; red [Runx1 alone]=78, green [Hes1 alone]=22, yellow 
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[co-expression]=22), suggesting that Runx1 may inhibit the Hes1 expression in DRG cells. 
Furthermore, we examined the co-localization of Runx1 and Notch1 intracellular domain 
(NICD), because Hes1 is downstream in the Notch signaling pathway. In Runx1
+/+
::Tg DRG 
at E12.5, many Runx1
+
 DRG cells co-expressed activated-Notch1 (Fig. 7), suggesting that 
Runx1 may regulate Hes1 through activating Notch1 within the same DRG cells. Taken 
together, these results suggest that Runx1 may regulate the neuronal differentiation of DRG 
cells by inhibiting the Hes1 expression at E12.5. 
 
 
Discussion 
 
In the present study, we examined the roles of Runx1 in the proliferation and differentiation 
of DRG neurons during the early embryonic period. We found that the Runx1 deficiency 
decreased the number of DRG neurons which express TrkA and three neuronal markers, Hu, 
NeuN, and Islet1, while the number of DAPI
+
 total DRG cells and caspase3
+
 apoptotic cells 
was not changed at E12.5. In addition, we showed that Runx1 deficiency increased both 
proliferating DRG cells and Hes1 expression in DRG. Taken together, it was suggested that 
Runx1 promotes the DRG neuronal differentiation by suppressing Hes1 expression at 
restricted time window in the early developmental stage.  
 
Roles of Runx1 in the cell proliferation and neuronal differentiation at early stage of 
DRG development 
   It was reported that Runx1 is initially expressed in TrkA
+
 DRG neurons and subsequently 
segregates these neurons into Runx1
+
/Ret
+
 nonpeptidergic nociceptive neurons and 
TrkA
+
/CGRP
+
 peptidergic nociceptive neurons by repressing the expression of TrkA and 
CGRP and activating c-Ret expression from the late embryonic through postnatal period 
(Chen et al., 2006b; Kramer et al., 2006; Marmigère et al., 2006; Yoshikawa et al., 2007). 
Although Runx1 plays crucial roles in the diversification of nociceptive DRG neurons from 
the late embryonic period, Runx1 is expressed as early as E12.5 (Chen et al., 2006b, Fig. S1), 
when there are many proliferating cells in DRG (Lawson and Biscoe, 1979). In addition, we 
have previously shown that Runx1 deficiency increased the proliferation of DRG cells during 
E11.5 and E13.5 (Yoshikawa et al., 2007). Taken together, these results suggest that Runx1 
may be involved in the proliferation and/or differentiation of DRG neurons at early 
embryonic stage. 
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   The present study revealed that the number of DRG neurons which express Hu, NeuN, 
Islet1, or TrkA was decreased in Runx1-deficient mice at E12.5, independent of the DAPI
+ 
total cell number and the caspase3
+
 apoptotic cells. Hu is a RNA-binding protein expressed 
during neurogenesis and promotes neuronal differentiation (Akamatsu et al., 2005; 
Wakamatsu et al., 1997). NeuN is a pan-neuronal marker expressed in differentiated neuron, 
and Islet1 is a transcription factor expressed in the process of neuronal specification of 
selected neurons including DRG neurons (Avivi et al., 1999). Considering the characteristics 
of these molecules, the present findings suggest that Runx1 is involved in promoting 
neuronal differentiation from the early stages of the neurogenesis. In addition, the cell cycle 
analysis suggested that Runx1 decreases the proliferation of DRG cells without changes in 
cell cycle length. Taken together, these results suggest that Runx1 has a role in suppressing 
the proliferation of DRG cells and promoting DRG neuronal differentiation.  
   In the present study, TrkA
+
 and NeuN
+
 neurons were decreased transiently at E12.5 but 
not E11.5 in Runx1
–/–
::Tg DRG. The failure of effects of Runx1 deficiency at E11.5 seems to 
be due to the insufficient expression of Runx1 to cause significant changes in the number of 
TrkA
+
 and NeuN
+ 
DRG neurons, because it was reported that Runx1 expression does not 
begin until E12.5 in DRG (Chen et al., 2006b). We previously reported that the number of 
TrkA
+
 neurons was increased in Runx1
–/–
::Tg DRG at E17.5 (Yoshikawa et al., 2007). This 
effect was explained by the suppression of TrkA expression by Runx1 (Chen et al., 2006b; 
Yoshikawa et al., 2007). In contrast, the present study showed the contradictory results that 
the number of TrkA
+
 neurons was reduced in Runx1
–/–
::Tg at E12.5. There seem to be at least 
two possibilities for the early decrease of TrkA
+
 neurons. First, Runx1 deficiency suppresses 
the DRG neuronal differentiation, which subsequently results in the reduction of the number 
of TrkA
+
 neurons at E12.5. In this case, Runx1 is not necessarily involved in the direct 
regulation of TrkA expression. This is highly possible considering that TrkA is expressed in 
postmitotic neurons committed to a sensory neuronal fate (Marmigère and Ernfors, 2007). 
The second possibility is that Runx1 induces the TrkA expression directly. In accordance with 
the second possibility, it was reported that overexpression of Runx1 induces precocious TrkA 
expression in migrating neural crest cells without promoting neuronal differentiation, and that 
the number of TrkA
+
 DRG neurons is decreased by Runx1 inhibition with transfection of 
Runx1 siRNA to DRG neurons in early developing chick embryos (Marmigère et al., 2006). 
Therefore, Runx1 may have dual functions in the regulation of TrkA expression depending on 
the developmental stages, activation at the early stage and suppression at later stage. In this 
case, different co-factors may be involved in the regulation of TrkA expression by Runx1. 
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Further analyses on the regulatory mechanisms of TrkA expression by Runx1 are needed to 
clarify the developmental context-dependent functions.  
   There seems to be some discrepancy in the effects of Runx1 inactivation on TrkA 
expression in previous reports. It was reported that Runx1 inactivation reduces of TrkA
+ 
neuronal number in early chick DRG and in early developing mouse trigeminal ganglion 
(Theriault et al., 2004; Marmigère et al., 2006). In contrast, we and Chen et al. reported that 
Runx1 inactivation increases TrkA
+
 neurons in mouse DRG at late embryonic and postnatal 
stages (Chen et al., 2006b; Yoshikawa et al., 2007). The present study showed that Runx1 
inactivation reduces TrkA
+
 neurons at the early embryonic period, in contrast to the increase 
of TrkA
+
 neurons at late embryonic stage in the same mouse strain (Yoshikawa et al., 2007). 
Therefore, it is possible the discrepancy regarding the Runx1 function in TrkA expression 
may be due to the differences of the developmental stages examined. 
   It was reported that Runx1 promotes the cell proliferation of ORN precursors in the 
olfactory epithelium (Theriault et al., 2005). In contrast, the present study showed the 
opposite function of Runx1 in suppression of the proliferation of DRG cells. In the olfactory 
epithelium, Runx1 is expressed in proliferating cells (Theriault et al., 2004). By contrast, in 
DRG, Runx1 is expressed in post-mitotic cells undergoing neuronal differentiation but not 
proliferating cells (Chen et al., 2006b; Marmigère et al., 2006; Yoshikawa et al., 2007, Fig. 
S1). Therefore, it is likely that Runx1 is different in the expression between proliferating 
ORN precursors and postmitotic DRG neurons and that Runx1 has different functions 
between these cells.   
 
Possible involvement of Hes1 in mediating the effects of Runx1 in the neuronal 
differentiation  
   The present study suggested that Runx1 promotes the differentiation of DRG neurons. To 
gain an insight into the molecular mechanisms mediating actions of Runx1 in the neuronal 
differentiation, we examined the expression of Hes1 which has been shown to suppress 
neuronal differentiation (Cau et al., 2000; Ishibashi et al., 1995; Iso et al., 2003; Guo et al., 
2008; Tomita et al., 1996). In Runx1
–/–
::Tg DRG, Hes1
+
 cells were increased, suggesting the 
possibility that the promotion of neuronal differentiation by Runx1 is mediated by the 
suppression of Hes1 expression. However, the regulatory mechanisms of Hes1 expression by 
Runx1 remain to be examined. It is possible that Runx1
+
 DRG neurons themselves do not 
express Hes1 and suppress Hes1 expression in cells undergoing neuronal differentiation 
which adjoin the Runx1
+
 DRG neurons (Fig. 8A). Alternatively, Runx1 suppresses Hes1 
expression cell-autonomously within the same cells (Fig. 8B). The first regulatory 
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mechanism seems to be plausible in DRG, considering the previous study showing that 
Runx1 is expressed in postmitotic (therefore Hes1-negative or weakly positive) DRG neurons. 
However, we could not exclude the second possibility that Hes1 is downstream to Runx1. In 
various types of cells including the olfactory epithelial cells, it has been shown that Runx1 
cofactor CBF-1 is involved in the regulation of Hes1 expression (Cau et al., 2000; Guo et al., 
2008; Ishibashi et al., Iso et al., 2003; 1995; Tomita et al., 1996).  
   To determine the mechanisms of the regulation of Hes1 expression by Runx1, we 
examined the co-localization of Runx1 and Hes1. The immunohistochemical analysis showed 
that many Runx1
+
 DRG cells did not express Hes1 at E12.5, but there were still some cell 
populations which expressed only Hes1 or both Runx1 and Hes1. We also examined Notch1 
expression in Runx1
+
 DRG cells. Hes1 is downstream of the Notch signaling pathway. When 
Delta-like1 binds to Notch1, Notch1 intracellular domain (NICD) is disconnected from 
Notch1 and translocated into nucleus. NICD then binds the nuclear protein CBF-1 and 
controls Hes1 transcription (Fig. 8C, Iso et al., 2003). When we examined co-localization of 
Runx1 and NICD, many Runx1
+
 DRG cells co-expressed NICD (activated-Notch1) at E12.5, 
suggesting that Runx1 may regulate Hes1 within the same cells. Taken together, it is possible 
that Runx1 inhibits the expression of Hes1 by binding to the transcriptional regulatory 
domain of Hes1 in DRG cells in Runx1
+/+
::Tg mice at E12.5. In Runx1
-/-
::Tg mice, Runx1 
does not bind the transcriptional regulatory domain of Hes1 and DRG neurons continue to 
express Hes1 (Fig. 8C). Therefore neuronal differentiation of DRG cells was suppressed in 
Runx1
-/-
::Tg mice compared with Runx1
+/+
::Tg mice at E12.5. Hes1 is expressed before 
Runx1 expression, and Runx1 may be under way to repress the Hes1 expression at E12.5. 
Accordingly, 22% of Runx1
+
 cells and 50% of Hes1
+
 cells co-express Hes1 and Runx1, 
respectively. Molecular approaches such as ChIP assay are needed to determine the 
mechanisms underlying the regulation of Hes1 expression by Runx1.  
  In summary, the present study suggested novel functions of Runx1 in the regulation of 
proliferation and neuronal differentiation of DRG neurons during the early stage of the 
development. Although the suppression of Hes1 expression may be involved in the promotion 
of neuronal differentiation by Runx1, further studies are needed to clarify the regulatory 
mechanisms. 
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Experimental Methods 
 
Animal maintenance and genotyping 
The strategy used to inactivate Runx1 in the mouse germline and rescue Runx1 gene knockout 
mice from embryonic lethality by expressing the Runx1 transgene in erythroid cells 
specifically was described previously (Okada et al., 1998; Okuda et al., 1996; Yokomizo et al., 
2007, Yoshikawa et al., 2007). Mice were bred in a clean room in the Laboratory Animal 
Resource Center at the University of Tsukuba. Transgenic Runx1
–/– 
mice (Runx1
–/–
::Tg) and 
the control Runx1
+/+
::Tg mice were obtained by mating Runx1
+/–
::Tg mice. Timed embryos 
were obtained by overnight mating, and the morning when the vaginal plug was observed 
was considered E0.5. The stages of mouse embryos were confirmed according to Kaufman 
(Kaufman, 1992). Runx1 mutant mice were genotyped using PCR as described previously 
(Okada et al., 1998) and a pair of primers, RUNT S1 
(5’-AGCATGGTGGAGGTACTAGC-3’) and RUNT AS1 
(5’-GGTCGTTGAATCTCGCTACC-3’) was used for Runx1 transgene detection. All 
experiments followed the Guide for the Care and Use of Laboratory Animals described by the 
National Institutes of Health (USA) and were approved by the Animal Experimentation 
Committee of the University of Tsukuba. 
 
Immunohistochemistry 
For cryostat sections, E11.5 and E12.5 whole mouse embryos were immersed two overnights, 
and E13.5 were immersed overnight at 4˚C in a fixative containing 4% paraformaldehyde in 
0.1 M phosphate buffer (pH 7.4). Whole mouse embryos were immersed in 0.1 M PB 
containing 20% sucrose overnight on ice and frozen in Tissue-Tek O. C. T. compound 
(Sakura Finetek, Japan). Ten m transverse serial sections of the trunk at thoracic segments 
were cut using a cryostat (HM 500 OM; Microm, Germany) and collected onto MAS-coated 
glass slides (Matsunami Glass, Japan) and air-dried for 1 h. If needed, sections were 
subjected to heat-induced epitope retrieval by heating to 105˚C for 8 min in Dako REALTM 
Target Retrieval Solution (Dako). After treatment for 30 min at room temperature (RT) with 
0.3% H2O2 in methanol to eliminate endogenous peroxidase reaction, the sections were 
incubated for 1 h at RT in a blocking solution containing 5% normal goat serum or 5% 
normal horse serum and 0.15% Triton X-100 in phosphate-buffered saline.  
   For immunohistochemical analysis, the following specific antibodies were used: mouse 
anti-NeuN (Chemicon; 1:6000), mouse anti-Islet1 (Developmental Studies Hybridoma Bank; 
1:200), rabbit anti-TrkA (RTA; a gift from Dr. L. F. Reichardt, University of California, San 
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Francisco, CA; 1:4000, Chemicon; 1:2000), goat anti-TrkC (R&D Systems; 1:2000), rabbit 
anti-Hes1 (Millipore; 1:2000), biotinylated mouse anti-Hu (Invitrogen; 1:400), rabbit 
anti-caspase3 (Promega; 1:2000) and rabbit anti-activated Notch1 (Abcam; 1:200) antibodies. 
The sections were incubated for 24 to 48 h at 4˚C with each of the primary antibodies. For 
single staining, the sections were incubated with anti-TrkA, anti-Hes1 or anti-TrkC antibody 
as described above, followed by the incubation with a biotinylated anti-rabbit or goat IgG 
antibody (Vector laboratories; 1:500) for 1 h at RT, and the peroxidase-conjugated 
avidin–biotin complex (ABC kit elite, Vector Laboratories; 1:100) for 30 min at RT. The 
sections incubated with anti-NeuN or anti-Islet1 were incubated with a HRP conjugated 
anti-rabbit IgG antibody (MBL; 1:600) for 1.5 h at RT. The sections incubated with 
biotinylated mouse anti-Hu were incubated with the peroxidase-conjugated avidin–biotin 
complex (1:100) for 30 min at RT. The positive reactions were visualized with ImmunoPure 
Metal Enhanced DAB Substrate kit (Pierce) for 7 min at RT. The sections incubated with 
anti-caspase3 were incubated with Alexa Fluor 488 labeled anti-rabbit IgG antibody 
(Invitrogen; 1:1000) for 1.5 h at RT. For double staining, cryostat sections were incubated 
with mouse anti-Runx1 and rabbit anti-Hes1 antibody two overnight at 4˚C, followed by 
incubation with Alexa Fluor 594 labeled anti-mouse IgG and Alexa Fluor 488 labeled 
anti-rabbit IgG antibody (Invitrogen; 1:1000) for 1.5 h at RT. Nuclear staining was performed 
with 4’, 6-diamidino-2-phenylindole (DAPI, Invitrogen; 100 ng/ml) for 10 min at RT. Images 
of immunostained sections were collected on a LSM510META confocal microscope (Carl 
Zeiss). Samples from Runx1
–/–
::Tg and Runx1
+/+
::Tg littermates were processed 
simultaneously for immunohistochemistry. 
 
Cell cycle analysis 
Cell cycle analysis was based on a previous paper (Martynoga et al., 2005). To estimate the 
cell cycle parameters; the number of S-phase and G2/M-phase cells and the length of S-phase, 
pregnant female mice 12.5 days after mating were injected intraperitoneally with 
5’-Indo-2’-deoxyuridine (IDU, Sigma, 50 mg/kg) at T = 0 h to label all cells in S-phase at 
start of the experiment (Fig. 5A). At T = 1.5 h, 5’-Bromo-2’-deoxyuridine (BrdU, Sigma, 50 
mg/kg) was injected and the embryos were fixed after 0.5 h, sufficient to label the S-phase 
cells at the end of the labeling period (Nowakowski et al., 1989). During the 1.5 h interval 
when cells are exposed to IDU but not BrdU, some of the initial S-phase cells would leave 
S-phase and consequently labeled with IDU (Leaving cells). For double immunostaining of 
BrdU and IDU, mouse anti-BrdU/IDU antibody (clone B44, 1:100 in blocking solution; 
Becton Dickinson) which recognizes both BrdU and IDU, and rat anti-BrdU antibody (clone 
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BU1/75, 1:400; Abcam) which recognizes BrdU but not IDU were used. The cryostat 
sections were incubated overnight at 4˚C with mouse anti-BrdU/IDU and rat anti-BrdU 
antibody, followed by Alexa Fluor 488 labeled anti-mouse IgG (Invitrogen; 1:1000) and 
Alexa Fluor 594 labeled anti-rat IgG antibody (Invitrogen; 1:1000) for 1.5 h at RT. BrdU/IDU 
double labeled cells were S-phase cells (S cells) and IDU single labeled cells G2/M-pahse 
cells (L cells). The length of S-phase (Ts) was calculated as follows: Ts = S cells / L cells × 
1.5 h. 
 
Cell counting, Measurement of DRG volume and statistical analysis 
DRGs at thoracic segments were serially sectioned at 10 m, and all the sections containing a 
particular DRG were immunostained by a single antibody and used for cell counting. For 
counts of Hu
+
 and Islet1
+
 DRG neurons, DRGs in the fifth thoracic segment (Th5) and Th7 
were serially sectioned, respectively. Serial sections of Th11 DRGs were used for counts of 
DAPI
+
, TrkA
+
, TrkC
+
, IDU
+
, BrdU
+
 and Hes1
+
 DRG cells, and those of Th13 DRGs were 
used for counts of NeuN
+
 and caspase3
+
 DRG cells. Images of DRG sections were captured 
with a CCD camera on an Axioplan2 microscope (Carl Zeiss) or an LSM510META confocal 
microscope (Carl Zeiss) using a 20x objective. As described previously (Nakamura et al., 
2008), cells were counted if they contained a nucleus and had a signal intensity in the 
cytoplasm or nucleus that was more than 2.5-fold above the noise level for that tissue section. 
For measurement of DRG volume, 10 m-thick serial sections containing whole DRGs 
(Th11) at E12.5 were used. The DRG areas in each section were measured and the DRG 
volume calculated using ImageJ image analysis software (NIH). Quantitative analyses were 
performed on three pairs of embryos from three independent pregnant mice. Statistical 
analyses were performed using the F test, followed
 
by the Student's t test. Differences were 
considered significant if the probability of error was less than 5%. All results are expressed as 
the mean ±SEM. 
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Figure legends 
 
Figure 1. Transient decrease of TrkA
+ 
DRG without changes of TrkC
+
 DRG neurons in 
Runx1
−/−
::Tg mice at E12.5. (A-F) Immunoreactivity of TrkA in DRG of Runx1
+/+
::Tg 
(A-C) and Runx1
−/−
::Tg (D-F) mice at E11.5 (A, D), E12.5 (B, E), E13.5 (C, F). Boxed areas 
of immunoreactive neurons are shown at higher magnification in the insets at the left bottom 
of each panel. (G) Quantification of the number of TrkA
+ 
DRG neurons in Runx1
+/+
::Tg 
(white bars) and Runx1
−/−
::Tg (black bars) mice from E11.5 to E13.5. (H, I) 
Immunoreactivity of TrkC in DRG of Runx1
+/+
::Tg (H) and Runx1
−/−
::Tg (I) mice at E12.5. 
Boxed areas of immunoreactive neurons are shown at higher magnification in the insets at the 
left bottom of each panel. (J) Quantification of the number of TrkC
+ 
DRG neurons in 
Runx1
+/+
::Tg (white bar) and Runx1
−/−
::Tg (black bar) mice at E12.5. Data are shown as 
mean ±SEM; ***p<0.001. Scale bars: 100 m in A-F, I.  
 
Figure 2. Decrease of NeuN
+ 
neurons in Runx1
−/−
::Tg DRG during early development. 
(A-F) Immunoreactivity of NeuN in DRG of Runx1
+/+
::Tg (A-C) and Runx1
−/−
::Tg (D-F) 
mice at E11.5 (A, D), E12.5 (B, E), E13.5 (C, F). Boxed areas of immunoreactive neurons are 
shown at higher magnification in the insets at the left bottom of each panel. (G) 
Quantification of the number of NeuN
+ 
DRG neurons in Runx1
+/+
::Tg (white bars) and 
Runx1
−/−
::Tg (black bars) mice from E11.5 to E13.5. Data are shown as mean ± SEM; 
*p<0.05, **p<0.01. Scale bars: 100 m in A-F.  
 
Figure 3. No changes in the total DRG cells, the DRG volume and the number of 
caspase3
+
 DRG cells in Runx1
−/−
::Tg mice. (A, B) DAPI-staining of DRG cells in 
Runx1
+/+
::Tg (A) and Runx1
−/−
::Tg (B) mice at E12.5. (C, D) Quantification of the total 
number of DRG cells (C) and the volume of DRG (D) in Runx1
+/+
::Tg (white bars) and 
Runx1
−/−
::Tg (black bars) mice. (E-H) Immunoreactivity of caspase3 in DRG of 
Runx1
+/+
::Tg (E, F) and Runx1
−/−
::Tg (G, H) mice at E11.5 (E, G) and E12.5. (F, H). (I) 
Quantification of the number of caspase3
+
 DRG cells in Runx1
+/+
::Tg (white bars) and 
Runx1
−/−
::Tg (black bars) mice at E11.5 and E12.5. Data are shown as mean ± SEM. Scale 
bars: 100 m in B, E-H. 
 
Figure 4. Decrease of Islet1
+ 
and Hu
+
 DRG neurons in Runx1
−/−
::Tg mice at E12.5. 
(A-D) Immunoreactivity of Islet1 (A, B) and Hu (C, D) in DRG of Runx1
+/+
::Tg (A, C) and 
Runx1
−/−
::Tg (B, D) mice at E12.5. Boxed areas of immunoreactive neurons are shown at 
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higher magnification in the insets at the left bottom of each panel. Islet1 is present in the 
nucleus and Hu is present mainly in the cytoplasm. (E, F) Quantification of the number of 
Islet1
+ 
(E) and Hu
+
 (F) DRG neurons in Runx1
+/+
::Tg (white bars) and Runx1
−/−
::Tg (black 
bars) mice at E12.5. Data are shown as mean ± SEM; *p<0.05, **p<0.01. Scale bar: 100 m 
in D.  
 
Figure 5. Increase of S-phase and G2/M-phase cells in Runx1
−/−
::Tg DRG at E12.5. (A) 
(A) Schematic illustration showing the experimental paradigm. (B, C) Double 
immunostaining images of BrdU (red) and IDU (green) in DRG of Runx1
+/+
::Tg (B) and 
Runx1
−/−
::Tg (C) mice at E12.5. Boxed areas of immunoreactive neurons are shown at higher 
magnification in the insets at the left bottom of each panel. Arrowheads indicate BrdU/IDU 
positive nucleus (yellow) of the S-phase cells (S cells) and arrows indicate IDU positive 
nucleus (green) of the G2/M-phase cells (Leaving [L] cells) (see Materials and Methods). 
(D-F) Quantification of the number of S cells (D), L cells (E), and the length of S-phase (Ts) 
(F)
 
in Runx1
+/+
::Tg (white bars) and Runx1
−/−
::Tg (black bars) mice at E12.5. Data are 
shown as mean ± SEM; *p<0.05. Scale bar: 100 m in C.  
 
Figure 6. Increase of Hes1
+
 cells in Runx1
−/−
:: Tg DRG at E12.5. (A-D) Immunoreactivity 
of Hes1 in DRG of Runx1
+/+
::Tg (A, C) and Runx1
−/−
::Tg (B, D) mice at E11.5 (A, B) and 
E12.5 (C, D). Boxed areas of immunoreactive cells are shown at higher magnification in the 
insets at the left bottom of each panel. (E) Quantification of the number of Hes1
+ 
DRG cells 
in Runx1
+/+
::Tg (white bars) and Runx1
−/−
::Tg (black bars) mice at E11.5 and E12.5. (F-H) 
Double immunostaining images of Runx1 (red in F, H) and Hes1 (green in G, H) in DRG of 
the wild-type mice at E12.5. Arrowheads indicate Hes1
+
/Runx1
−
 nucleus (G, H) and arrows 
indicate Hes1
+
/Runx1
+
 nucleus (H) of DRG cells. Data are shown as mean ± SEM; *p<0.05. 
Scale bars: 100 m in A-D, H. 
 
Figure 7. Co-expression of Runx1 and activated-Notch1 in DRG at E12.5. (A-C) Double 
immunostaining images of Runx1 (red in A, C) and activated-Notch1 (green in B, C) in DRG 
of Runx1
+/+
::Tg mice at E12.5. Arrowheads indicate activated-Notch1
+
/Runx1
+
 cells. Scale 
bars: 100 m in C. 
 
Figure 8. Models of regulation of Hes1 transcription by Runx1. (A, B) Two possibilities 
of the regulatory mechanisms of Hes1 expression by Runx1. Runx1
+
 DRG neurons do not 
express Hes1 and repress Hes1 expression in cells undergoing neuronal differentiation which 
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adjoin the Runx1
+
 neurons (A). Runx1 suppresses Hes1 expression cell-autonomously within 
the same cells (B). (C) In Notch signal system, Hes1 expression is controlled by Notch1 
intracellular domain (NICD) (Iso et al., 2003). When Delta-like1 (Dll1) binds to Notch1, 
NICD is disconnected from Notch1 and translocated into nucleus. Then NICD binds the 
nuclear protein CBF-1 and promotes Hes1 transcription. It is possible that Runx1 inhibits the 
Hes1 transcription by binding to the transcriptional regulatory domain (TRD) of Hes1 in 
DRG neurons of Runx1
+/+
::Tg mice. In Runx1
-/-
::Tg mice, Runx1 does not bind the 
transcriptional regulatory domain of Hes1 and DRG neurons continue to express Hes1. 
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Table 1. Number of DRG cell subtypes in Runx1+/+::Tg and Runx1-/-::Tg  mice 
in early developmental stage
Runx1+/+::Tg Runx1-/-::Tg
Number of TrkA
+
 DRG neurons
E11.5 710.8 ± 32.8 (6) 719.8 ± 13.0 (6)
E12.5 1035.4 ± 31.9 (6) 734.3 ± 35.8 (6)***
E13.5 2422.4 ± 61.6 (6) 2434.5 ± 57.6 (6)
Number of TrkC
+
 DRG cells
E12.5 239.0 ± 7.6 (6) 264.8 ± 10.5 (6)
Number of NeuN
+
 DRG neurons
E11.5 1234.8 ± 43.4 (6) 1211.8 ± 52.7 (6)
E12.5 2443.0 ± 134.0 (6) 2057.8 ± 36.6 (6)*
E13.5 6574.6 ± 112.5 (6) 5922.8 ± 140.0 (6)**
Number of DAPI
+
 DRG cells
E12.5 6120.3 ± 79.1 (6) 6142.2 ± 93.0 (6)
Number of caspase3
+
 DRG cells
E11.5 166.2 ± 27.7 (5) 172.2 ± 72.8 (5)
E12.5 72.8 ± 18.8 (6) 86.6 ± 27.5 (6)
Number of Islet1
+
 DRG neurons
E12.5 1706.4 ± 64.0 (6) 1437.8 ± 88.2 (6)*
Number of Hu
+
 DRG neurons
E12.5 1821.3 ± 49.0 (6) 1607.5 ± 45.6 (6)**
Statistical analyses were performed by F  test, followed by Student's t  test.
Data are presented as mean ± SEM. The number of DRGs is shown in parentheses.
*P <0.01; **P <0.05; ***P <0.001. 
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